Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Flow-mediated vasodilation in end-stage renal disease.

Verbeke FH, Pannier B, Guérin AP, Boutouyrie P, Laurent S, London GM.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2009-15. doi: 10.2215/CJN.01260211. Epub 2011 Jul 22.

2.

Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in hemodialysis patients.

De Vriese AS, De Bacquer DA, Verbeke FH, De Winter O, Franken PR, De Sutter JH, Walgraeve N, Missault L, De Geeter FW.

Kidney Int. 2009 Aug;76(4):428-36. doi: 10.1038/ki.2009.160. Epub 2009 Jun 3.

3.

Local shear stress and brachial artery functions in end-stage renal disease.

Verbeke FH, Agharazii M, Boutouyrie P, Pannier B, Guérin AP, London GM.

J Am Soc Nephrol. 2007 Feb;18(2):621-8. Epub 2007 Jan 3.

4.

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.

London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F.

J Am Soc Nephrol. 2007 Feb;18(2):613-20. Epub 2007 Jan 3.

5.

Forearm reactive hyperemia and mortality in end-stage renal disease.

London GM, Pannier B, Agharazii M, Guerin AP, Verbeke FH, Marchais SJ.

Kidney Int. 2004 Feb;65(2):700-4.

Supplemental Content

Loading ...
Support Center